MeiraGTx Holdings plc Fair Value Adjustment of Warrants
MeiraGTx Holdings plc (MGTX) reported Fair Value Adjustment of Warrants of $1.51 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-03-11
- MeiraGTx Holdings plc fair value adjustment of warrants for the quarter ending 2018-12-31 was $0.00.
- MeiraGTx Holdings plc fair value adjustment of warrants for the quarter ending 2018-09-30 was $0.00.
- MeiraGTx Holdings plc fair value adjustment of warrants for the quarter ending 2018-06-30 was $2.18M.
- MeiraGTx Holdings plc fair value adjustment of warrants for the quarter ending 2018-03-31 was -$669.41K.
- MeiraGTx Holdings plc fair value adjustment of warrants for fiscal 2018 was $1.51M, a 225.32% increase from fiscal 2017.
- MeiraGTx Holdings plc fair value adjustment of warrants for fiscal 2017 was $465.63K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $2.18M derived: sum of 3 quarters · filed 2020-03-11 | $1.51M 10-K · filed 2020-03-11 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.18M derived: sum of 2 quarters · filed 2019-11-07 | $1.51M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.18M 10-Q · filed 2019-08-07 | $1.51M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$669.41K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $465.63K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |